Structure and signalling in the IL-17 receptor family
Open accessThe DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Interleukin-17A (IL-17A), the hallmark cytokine of the newly defined T helper 17 (T(H)17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease. IL-17A and its receptor (IL-17RA) are the founding members of a newly described family of cytokines and receptors that have unique structural features which distinguish them from other cytokine families. Research defining the signal transduction pathways induced by IL-17R family cytokines has lagged behind that of other cytokine families, but studies in the past 2 years have begun to delineate unusual functional motifs and new proximal signalling mediators used by the IL-17R family to mediate downstream events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“most documented IL-17R signaling occurs in non-hematopoietic cells, particularly cells of epithelial and mesenchymal origin [44,45].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Cited by
Items 601–700 of 1,001
Tofacitinib: A New Oral Therapy for Psoriasis
Azevedo, A., & Torres, T. R. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0596-y · Cited by 41
Nuclear Factor Kappa B in Autism Spectrum Disorder: A Systematic Review
Liao, X., & Li, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104918 · Cited by 43
IL-17A Modulates Oxidant Stress-Induced Airway Hyperresponsiveness but Not Emphysema
Pinart, M., Zhang, M., Li, F., Hussain, F., Zhu, J., Wiegman, C., Ryffel, B., & Chung, K. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058452 · Cited by 37
“The IL-17 receptor (IL-17R) family comprises five receptor subunits, of which IL-17RA is the largest member and is necessary for IL-17Amediated signal transduction [7].”
BackgroundHuang, G., Wang, Y., Vogel, P., & Chi, H. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2147 · Cited by 37
“p38a mediates IL-17–induced proinflammatory gene expression and MK2 activation IL-17, the signature cytokine for TH17 cells, stimulates inflammation in autoimmune diseases (9, 30, 31).”
Wu, J., Guo, J., Cao, Q., Wáng, Y., Chen, J., Wang, Z., & Yuan, Z. (2016) · Oncology Letters · doi:10.3892/ol.2016.5476 · Cited by 37
Relationship between various cytokines implicated in asthma
ayakannu, R., Abdullah, N. A., Radhakrishnan, A. K., Raj, V. L., & Liam, C. K. (2019) · Human Immunology · doi:10.1016/j.humimm.2019.04.018 · Cited by 46
CIKS/DDX3X Interaction Controls the Stability of the Zc3h12a mRNA Induced by IL-17
Somma, D., Mastrovito, P., Grieco, M., Lavorgna, A., Pignalosa, A., Formisano, L., Salzano, A. M., Scaloni, A., Pacifico, F., Siebenlist, U., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401589 · Cited by 36
“Th17 cells and belongs to a molecular family composed of six members (IL-17A–F), which are structurally unrelated to other cytokines (1, 2).”
BackgroundWang, T., Zhou, Y., Wang, K., Jiang, X., Wang, J., & Chen, J. (2022) · Medicine · doi:10.1097/md.0000000000029762 · Cited by 36
“IL-17 inhibits fungal infections to a certain extent and exhibits pro-inflammatory properties.[31,32] Therefore, high levels of IL-17 in the blood lead to heightened inflammatory responses, promoting plaque growth in the blood vessels or making the plaque unstable and aggravating atherosclerosis.”
BackgroundImmunotherapies in chronic pain through modulation of neuroimmune interactions
Zhao, J., Huh, Y., Bortsov, A. V., Diatchenko, L. B., & Ji, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108476 · Cited by 43
Th17 Cells, Glucocorticoid Resistance, and Depression
Khantakova, J. N., Mutovina, A., Ayriyants, K. A., & Bondar, N. P. (2023) · Cells · doi:10.3390/cells12232749 · Cited by 38
“F [61,65].”
BackgroundInterleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma
Ferretti, E., Carlo, E. D., Ognio, E., Guarnotta, C., Bertoni, F., Corcione, A., Prigione, I., Orcioni, G. F., Ribatti, D., Ravetti, J. L., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1030560 · Cited by 40
“The biological effects of IL-17 family cytokines are mediated by five different receptor (R) subunits (RA, RB, RC, RD, RE), that are single transmembrane domain-containing proteins which can heterodimerize or homodimerize in different combinations.(2) The heterodimer formed by IL-17RA and IL-17RC binds IL-17A, IL-17F…”
BackgroundInfluentialMojsilović, S. B., Jauković, A., Santibanez, J. F., & Bugarski, D. S. (2015) · Mediators of Inflammation · doi:10.1155/2015/470458 · Cited by 44
“[19] S.”
BackgroundExtensive Expression Differences along Porcine Small Intestine Evidenced by Transcriptome Sequencing
Mach, N., Berri, M., Esquerré, D., Chevaleyre, C., Lemonnier, G., Billon, Y., Lepage, P., Oswald, I. P., Dore, J. M., Rogel-Gaillard, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088515 · Cited by 40
“IL17REL, which oligomerizes and binds specific IL17 cytokines [27] and ITGB1BP3), whereas not even a single read could be detected in the distinct anatomical parts of the small intestine.”
BackgroundIL-12 and IL-23 modulate plasticity of FoxP3 + regulatory T cells in human Leprosy
Tarique, M., Saini, C., Naqvi, R. A., Khanna, N., Sharma, A., & Rao, D. N. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.01.008 · Cited by 39
Park, S. K., Jin, Y., Park, Y.-K., Yeon, S.-H., Xu, J., Han, R., Rha, K., & Kim, Y. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181806 · Cited by 40
Anterior Pituitary Transcriptome Suggests Differences in ACTH Release in Tame and Aggressive Foxes
Hekman, J. P., Johnson, J. L., Edwards, W. D., Vladimirova, A. V., Gulevich, R. G., Ford, A. L., Kharlamova, A. V., Herbeck, Y. E., Acland, G. M., Raetzman, L. T., et al. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300508 · Cited by 38
Pisitkun, P., Claudio, E., Ren, N., Wang, H., & Siebenlist, U. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27653 · Cited by 36
Zhang, H., Chen, J., Liu, X., Awar, L., McMickle, A., Bai, F., Nagarajan, S., & Yu, S. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12030 · Cited by 38
Characterization of Il-17Aa and Il-17Ff in Rheumatoid Arthritis and Multiple Sclerosis
Schofield, C., Fischer, S. K., Townsend, M. J., Mosesova, S., Peng, K., Setiadi, A. F., Song, A., & Baruch, A. (2016) · Bioanalysis · doi:10.4155/bio-2016-0207 · Cited by 39
Update on the role of Interleukin 17 in rheumatologic autoimmune diseases
Konya, C., Paz, Z., Apostolidis, S. A., & Tsokos, G. C. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.003 · Cited by 35
Yogarajah, J., Gouveia, C., Iype, J. M., Haefliger, S., Schaller, A., Nuoffer, J., Fux, M., & Gautschi, M. (2021) · Skin Health and Disease · doi:10.1002/ski2.25 · Cited by 43
Innate lymphoid cells: new players in IL-17-mediated antifungal immunity
Gladiator, A., & LeibundGut-Landmann, S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003763 · Cited by 35
“This results in the production of antimicrobial compounds and inflammatory mediators including G-CSF and CXC chemokines, which are believed to be the primary basis for recruitment and activation of neutrophils [1].”
BackgroundLiu, A. C., Lee, M. W., McManus, B. M., & Choy, J. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102527 · Cited by 36
“IL-17 binds to a heteromeric receptor composed of IL-17RA and IL-17RC subunits, and stimulation of cells with IL-17 leads to activation of the canonical NF-kB, MEK-ERK1/2, PI3K-Akt, JNK, and p38 MAPK pathways (5).”
BackgroundYoshikawa, F. S. Y., Yabe, R., Iwakura, Y., de Almeida, S. R., & Saijo, S. (2016) · Innate Immunity · doi:10.1177/1753425916645392 · Cited by 45
Interleukin-17A directly acts on bronchial smooth muscle cells and augments the contractility
Chiba, Y., Tanoue, G., Suto, R., Suto, W., Hanazaki, M., Katayama, H., & Sakai, H. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.12.007 · Cited by 35
Walliser, I., & Göbel, T. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2017.11.004 · Cited by 44
Vrgoč, G., Vrbanec, J., Eftedal, R. K., Lederer-Dembic, P., Balen, S., Dembić, Z., & Jotanović, Z. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23823 · Cited by 35
“IL- 17A had 10–30-fold stronger downstream gene activation potential than IL-17F.(32) In RA, IL-17A and IL-17F affected the synoviocytes by stimulating similar yet different signaling pathways.”
BackgroundInfluentialWarda, A. K., Bettio, P. H. D. A., Hueston, C. M., Benedetto, G. D., Clooney, A. G., & Hill, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00069 · Cited by 38
The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis.
Zeichner, J., & Armstrong, A. W. (2016) · Europe PMC (PubMed Central) · Cited by 46
Zheng, J., Chen, D., Xu, J., Ding, X., Wu, Y., Shen, H. C., & Tan, X. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128229 · Cited by 36
IL-17A attracts inflammatory cells in murine lung infection with P. aeruginosa
Wonnenberg, B., Jungnickel, C., Honecker, A., Wolf, L., Voss, M., Bischoff, M., Tschernig, T., Herr, C., Bals, R., & Beißwenger, C. (2016) · Innate Immunity · doi:10.1177/1753425916668244 · Cited by 36
Therapeutic potential of targeting IL-17 and its receptor signaling in neuroinflammation
Gautam, A. S., & Singh, R. K. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103517 · Cited by 36
Therapeutic Potential of IL‐17‐Mediated Signaling Pathway in Autoimmune Liver Diseases
Zhang, H., Bernuzzi, F., Lleò, A., Ma, X., & Invernizzi, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/436450 · Cited by 38
“tracellular-fibronectin III-like (FnIII) domain, and an intracellular SEF/IL-17R (SEFIR) domain [29, 50].”
BackgroundRamani, K., Jawale, C. V., Verma, A. H., Coleman, B. M., Kolls, J. K., & Biswas, P. S. (2018) · JCI Insight · doi:10.1172/jci.insight.98241 · Cited by 34
Niwa, M., Fujisawa, T., Mori, K., Yamanaka, K., Yasui, H., Suzuki, Y., Karayama, M., Hozumi, H., Furuhashi, K., Enomoto, N., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800147 · Cited by 39
IL-17A-stimulated endothelial fatty acid β-oxidation promotes tumor angiogenesis
Wang, R., Lou, X., Feng, G., Chen, J., Zhu, L., Liu, X., Yao, X., Li, P., Wan, J., Zhang, Y., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.030 · Cited by 40
FYN–TRAF3IP2 induces NF-κB signaling-driven peripheral T-cell lymphoma
Moon, C. S., Reglero, C., Cortés, J. R., Quinn, S. A., Álvarez, S., Zhao, J., Lin, W.-H. W., Cooke, A. J., Abate, F., Soderquist, C. R., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00161-w · Cited by 37
Andrews, M. D., Dack, K. N., de Groot, M. J., Lambert, M., Sennbro, C. J., Larsen, M., & Stahlhut, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00422 · Cited by 38
Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases
Yamagata, T., Skepner, J. E., & Yang, J. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0362-x · Cited by 40
“In addition, the signaling of both IL-17A and IL-17F requires both IL-17RA and IL-17RC (Gaffen 2009; Miossec and Kolls 2012).”
BackgroundWang, W., Fan, Y. Q., Lv, Z., Yao, X., Wang, W., Huang, K., Meng, Q., Fang, C., Lee, T. H., Corrigan, C. J., et al. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04062.x · Cited by 36
The Possible Role of IL-17 in Obesity-Associated Cancer
Gislette, T., & Chen, J. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.212 · Cited by 32
“IL-17 can stimulate the production of IL-6 by activation of a few signaling pathways, such as the NF-κB[20], Stat3, or PI3K/Akt pathways[21].”
BackgroundZhong, W., Xu, X., Zhu, Z., Li, Y., Du, H., Xia, Z., Yuan, Z., Xiong, H., Du, Q., Wei, Y., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4299 · Cited by 33
“We successfully knocked down IL-17R expression in the SU-DHL-4 cells using lentiviral-mediated shRNA, resulting in the significant down-regulation of IL-17R protein levels in the SU-DHL-4 cells (Fig.”
InfluentialFarouk, S., Sabet, S., Zahra, F. A. A., & El-Ghor, A. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206130 · Cited by 36
Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas
Dawod, B., Liu, J., Gebremeskel, S., Yan, C. W., Sappong‐Kumankumah, A., Johnston, B., Hoskin, D. W., Marshall, J. S., & Wang, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-70231-7 · Cited by 37
Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC
Wang, C., Chu, P., Chen, Y., Lin, Y.-H., & Chen, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413627 · Cited by 35
“Rather, IL-17 signals through nuclear factor (NF)-κB [44], mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) [45] signaling pathways.”
BackgroundOlveira, A., Augustín, S., Benlloch, S., Ampuero, J., Suárez‐Pérez, J. A., Armesto, S., Vilarrasa, E., Belinchón, I., Herranz, P., Crespo, J., et al. (2023) · Life · doi:10.3390/life13020419 · Cited by 44
“The liver is also one of the main producers of IL-17, and the IL-17 receptor is widely expressed in liver cells, such as hepatocytes, sinusoidal cells, biliary cells and stellate cells [31,32].”
BackgroundEsendağlı, G., Kurne, A., Sayat, G., Kılıç, A. K., Güç, D., & Karabudak, R. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.10.009 · Cited by 33
“…interaction between IL-17 and its receptor which is broadly expressed on a variety of cells including cells of myeloid origin and epithelial cells, leads to exacerbation of immune responses via upregulation of proinflammatory cytokines, chemokines and proteases (Gaffen, 2009; Akdis et al., 2011).”
BackgroundNi, J., Hu, G., Xiong, J., Shen, J., Shen, J., Yang, L., Tang, M., Zhao, Y. F., Ying, G., Yu, G., et al. (2012) · Inflammation · doi:10.1007/s10753-012-9519-5 · Cited by 33
Hecker, M., Paap, B. K., Goertsches, R. H., Kandulski, O., Fatum, C., Koczan, D., Hartung, H., Thiesen, H., & Zettl, U. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029648 · Cited by 34
Hamilton, T., Li, X., Novotny, M., Pavicic, P. G., Datta, S., Zhao, C., Hartupee, J., & Sun, D. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811404 · Cited by 32
“The IL-17R is composed of two chains (IL-17RA and IL17RC), and signaling depends on an intracellular protein domain termed SEFIR, which has some structural similarity to TLRs [87, 88] (see Fig.”
BackgroundElsonbaty, S. M., & Ismail, A. F. M. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108382 · Cited by 32
Bosmann, M., Patel, V. R., Russkamp, N. F., Pache, F. C., Zetoune, F. S., Sarma, J. V., & Ward, P. A. (2011) · The FASEB Journal · doi:10.1096/fj.11-191205 · Cited by 37
Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
Knight, V., Merkel, P. A., & O'Sullivan, M. D. (2016) · Antibodies · doi:10.3390/antib5010003 · Cited by 37
“There are six members of the interleukin-17 cytokine family, namely IL-17 A through F [62].”
BackgroundEspada, A., Broughton, H. B., Jones, S. B., Chalmers, M. J., & Dodge, J. A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01693 · Cited by 34
Ma, H., Xu, J., Liu, X., Zhu, Y., Gao, B., Karin, M., Tsukamoto, H., Jeste, D. V., Grant, I., Roberts, A. J., et al. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0097-3 · Cited by 34
Zhang, N., Ma, Z. P., Ju, W., Bai, H. L., Li, Y. X., Sun, Q., Yang, L., Lin, T., Zhao, J. H., Cao, Y. W., et al. (2016) · Europe PMC (PubMed Central) · Cited by 43
The Role of Th17 Cells and IL-17 in Th2 Immune Responses of Allergic Conjunctivitis
Meng, X.-T., Shi, Y.-Y., Zhang, H., & Zhou, H. (2020) · Journal of Ophthalmology · doi:10.1155/2020/6917185 · Cited by 38
“Meanwhile, when natural Tcells are activated under the action of transforming growth factor β (TGF-β) and IL-6 and IL-23 secreted by APC, signal transduction and activation of transcription factor 3 (STAT3) and RORC2 are activated to differentiate into +17 cells [82, 84].”
BackgroundInfluentialMangan, P. R., Su, L. J., Jenny, V., Tatum, A. L., Picarillo, C., Skala, S., Ditto, N. T., Lin, Z., Yang, X., Cotter, P., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.224246 · Cited by 33
“Moreover, IL-17RA–deficient mice likely elicit a more comprehensive blockade of all forms of IL-17, including IL-17F, since IL-17A/A, IL-17A/F, and IL-17F/F all require IL-17RA for signaling (Gaffen, 2009).”
BackgroundTran, E., Nielsen, J. S., Wick, D. A., Ng, A. V., Johnson, L. D. S., Nesslinger, N. J., McMurtrie, E., Webb, J. R., & Nelson, B. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015625 · Cited by 36
“cells [4]) was correlated with increased overall survival [5].”
BackgroundNordlohne, J., Helmke, A., Ge, S., Rong, S., Chen, R., Waisman, A., Haller, H. G., & von Vietinghoff, S. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.08.005 · Cited by 33
“Human IL-17 receptor A is central for IL-17A signaling similar to mouse (51).”
BackgroundSakhaei, R., Shahvazi, S., Mozaffari–Khosravi, H., Samadi, M., Khatibi, N., Nadjarzadeh, A., Zare, F., & Salehi‐Abargouei, A. (2018) · Food and Nutrition Bulletin · doi:10.1177/0379572118783950 · Cited by 37
Wang, Y., Li, W., Zhao, T., Zou, Y., Deng, T., Yang, Z., Yuan, Z., Ma, L., Yu, R., Wang, T., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.667768 · Cited by 37
The Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment
Paroli, M., Spadea, L., Caccavale, R., Spadea, L., Paroli, M. P., & Nante, N. (2022) · Medicina · doi:10.3390/medicina58111552 · Cited by 39
What’s new in asthma pathophysiology and immunopathology?
Orihara, K., Dil, N., Anaparti, V., & Moqbel, R. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.57 · Cited by 39
The role of Th1 and Th17 cells in glomerulonephritis.
Azadegan‐Dehkordi, F., Bagheri, N., Shirzad, H., & Rafieian‐Kopaei, M. (2015) · PubMed Central · doi:10.12860/jnp.2015.07 · Cited by 31
“IL-17B, IL-17C, IL-17D, IL-17E, IL-17F and the receptors IL-17RA, IL-17RB, IL-17RC, IL-17RD, and IL-17RE (26).”
Dynamics of Th17 associating cytokines in Cryptosporidium parvum-infected mice
Zhao, G., Fang, Y. Q., Ryan, U. M., Guo, Y., Wu, F., Du, S.-Z., Chen, D. K., & Lin, Q. (2015) · Parasitology Research · doi:10.1007/s00436-015-4831-2 · Cited by 34
IL-17E synergizes with EGF and confersin vitroresistance to EGFR-targeted therapies in TNBC cells
Merrouche, Y., Fabre, J., Curé, H., Garbar, C., Fuselier, C., Bastid, J., Antonicelli, F. D., Al‐Daccak, R., Bensussan, A., & Giustiniani, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10804 · Cited by 35
“Thus, IL-17E-induced resistance to anti-EGFR treatments conferred by Src activation and STAT3 and EGFR translocation is at least partially under the control of the IL-17E receptor, IL17RA/IL17RB, thus raising the question of whether it is involved in the treatment resistance associated with IL-17A and IL-17B, which sh…”
BackgroundFunction of Act1 in IL-17 Family Signaling and Autoimmunity
Wu, L., Zepp, J. A., & Li, X. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_13 · Cited by 36
Liang, J., Huang, F., Hao, X., Zhang, P., & Chen, R. (2024) · MedComm · doi:10.1002/mco2.727 · Cited by 40
“56 CD96 is a receptor belonging to the immunoglobulin superfamily and is involved in inflammatory responses.”
BackgroundLi, B., Lin, R., Hua, Y., Ma, B., & Chen, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-03068-z · Cited by 45
Neutrophils negatively regulate induction of mucosal IgA responses after sublingual immunization
Jee, J., Bonnegarde-Bernard, A., Duverger, A. E., Iwakura, Y., Cormet‐Boyaka, E., Martin, T. L., Steiner, H. E., Bachman, R. C., & Boyaka, P. N. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.105 · Cited by 32
“Th1 and Th2 cytokines, which activate JAK–STAT signaling pathways, signaling through IL-17R activates Act1 for subsequent activation of the classical nuclear factor kB (NF-kB) signaling pathway.(10) Furthermore, IL-17A directly triggers Ig class switching to IgG2a and IgG3, but not to IgG1.”
BackgroundIL-17 in the Rheumatologist’s Line of Sight
Truchetet, M., Mossalayi, M. D., & Boniface, K. (2013) · BioMed Research International · doi:10.1155/2013/295132 · Cited by 32
“In addition, IL-17 exists as a homodimer or as a heterodimer with IL-17F [10, 11].”
BackgroundInfluentialA highly sensitive and selective impedimetric aptasensor for interleukin-17 receptor A
Jo, H., Kim, S.-K., Youn, H., Lee, H., Lee, K., Jeong, J., Mok, J., Kim, S., Park, H., & Ban, C. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.02.050 · Cited by 30
“In particular, it is known that IL-17A can induce the expression of various inflammatory mediators and regulate the activities of inflammatory cells (Forlow et al. 2001; Linden and Adachi 2002; Sarma et al. 2009).”
BackgroundInfluentialTofacitinib for the treatment of psoriasis
Galluzzo, M., D’Adamio, S., Servoli, S., Bianchi, L., Chimenti, S., & Talamonti, M. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1195812 · Cited by 33
“sion [13] and cytokine production, for example, IL6, TNF-α, and”
BackgroundChamoun, M. N., Blumenthal, A., Sullivan, M. J., Schembri, M. A., & Ulett, G. C. (2018) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1426556 · Cited by 32
“…the transcription factors, NF-Kb, MAPK, and C/EBPs; however, in the case of TLRs, the signalling pathway is (instead) mediated through the adaptor proteins, Myeloid differentiation primary response gene 88 (MyD88) and TIRdomain-containing adapter-inducing interferon-b (TRIF) (Gaffen 2009).”
BackgroundInfluentialRamani, K., Tan, R. J., Zhou, D. F., Coleman, B. M., Jawale, C. V., Liu, Y., & Biswas, P. S. (2018) · Mediators of Inflammation · doi:10.1155/2018/5103672 · Cited by 33
“Fewer resources have been dedicated on defining downstream signaling via IL-17R on target cells [33, 39].”
Interleukin-17 receptor D (Sef) is a multi-functional regulator of cell signaling
Pande, S., Yang, X., & Friesel, R. E. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-020-00695-7 · Cited by 31
“Sef exhibited overlapping patterns of spatiotemporal expression with fgf3, fgf8, fgf17 and spry4 in these embryos, suggesting that these genes function together in a common pathway, constituting the fgf synexpression group [1, 2, 8].”
BackgroundWu, H., Tsai, L., Huang, C.-K., Hsu, P., Chen, M., Chen, Y. M., Hu, C., Shen, C., Lee, C., Chang, M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc2823 · Cited by 34
Kutwin, M., Migdalska‐Sęk, M., Brzeziańska‐Lasota, E., Zelga, P. J., & Woźniacka, A. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245834 · Cited by 35
IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC
Kang, J. H., Park, S., Rho, J., Hong, E.-J., Cho, Y., Won, Y., & Kwon, H. (2022) · Gastric Cancer · doi:10.1007/s10120-022-01342-5 · Cited by 33
“Given that IL-17RA and IL-17RC are differentially expressed by hematopoietic and non-hematopoietic cells [50], the IL-17RA/IL-17RC ratio is postulated to regulate IL-17A-induced cell response in a cell type-dependent manner.”
BackgroundLambert, S., Swindell, W. R., Tsoi, L. C., Stoll, S. W., & Elder, J. T. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.032 · Cited by 32
IL-17 deficiency attenuates acetaminophen-induced hepatotoxicity in mice
Lee, H.-C., Liao, C.-C., Day, Y., Liou, J.-T., Li, A. H.-L., & Liu, F.-C. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.04.021 · Cited by 35
Interventions in cytokine signaling: novel horizons for psoriasis treatment
Li, L., Liu, J., Lu, J., Wu, J., Zhang, X., Ma, T., Wu, X., Zhu, Q., Chen, Z., & Tai, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1573905 · Cited by 39
“A potential cause is that IL-9 binds to a receptor complex made up of IL-9RA and the common gamma chain, which engages the MAPK, phosphoinositide 3-kinase (PI3K), and Jak-STAT signaling networks (144).”
IκBNS Regulates Murine Th17 Differentiation during Gut Inflammation and Infection
Annemann, M., Wang, Z., Plaza‐Sirvent, C., Glauben, R., Schuster, M., Sander, F. E., Mamareli, P., Kühl, A. A., Siegmund, B., Lochner, M., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401964 · Cited by 36
“IL-17A, which is a potent inducer of other proinflammatory cytokines, such as IL-6, IL-1b, and TNF-a, in a variety of IL17R–expressing cell types, including endothelial cells, epithelial cells, and macrophages (7, 8).”
BackgroundIntegrating the pathogenesis of spondyloarthritis: gut and joint united?
Wilde, K. D., Debusschere, K., Beeckman, S., Jacques, P., & Elewaut, D. S. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000144 · Cited by 37
“Furthermore, blocking IL17RA in mice is sufficient to counteract IL17A and IL17F signalling.”
BackgroundInfluentialIL-17A synergistically enhances TNFα-induced IL-6 and CCL20 production in 3T3-L1 adipocytes
Shinjo, T., Iwashita, M., Yamashita, A., Sano, T., Tsuruta, M., Matsunaga, H., Sanui, T., Asano, T., & Nishimura, F. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.049 · Cited by 33
Genome-wide interaction study of dust mite allergen on lung function in children with asthma
Forno, E., Sordillo, J. E., Brehm, J. M., Chen, W., Benos, T., Yan, Q., Ávila, L., Soto-Quirós, M., Cloutier, M. M., Colón‐Semidey, A., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.12.967 · Cited by 29
“CEBPb is one of the mediators of IL-17A and IL-17F signaling pathways, as well as nuclear factor kappa B signaling.(37,38) CEBPb is also involved in IL-4, IL-6, and other signaling pathways (not shown).”
BackgroundCouderc, E., Morel, F., Levillain, P., Buffière-Morgado, A., Camus, M., Paquier, C., Bodet, C., Jégou, J., Pohin, M., Favot, L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181486 · Cited by 31
IL-33 Attenuates Sepsis by Inhibiting IL-17 Receptor Signaling through Upregulation of SOCS3
Lv, R., Zhao, J., Lei, M., Xiao, D., Yu, Y., & Xie, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479836 · Cited by 34
Interleukin-17: Functional and Structural Features, Application as a Therapeutic Target
Kostareva, O. S., Gabdulkhakov, A. G., Kolyadenko, I., Garber, M., & Tishchenko, S. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919140116 · Cited by 36
Kaul, M., Jarvis, P., Rozenberg, I., Kolbinger, F., Padova, F. D., Calonder, C., Espié, P., Rondeau, J., Cèbe, R., Huber, T., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17071 · Cited by 29
The Many Faces of JAKs and STATs Within the COVID-19 Storm
Grant, A. H., Estrada, A. X., Ayala-Marin, Y. M., Alvidrez-Camacho, A. Y., Rodriguez, G., Robles‐Escajeda, E., Cadena-Medina, D. A., Rodriguez, A. C., & Kirken, R. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690477 · Cited by 32
“IL‐17A–IL‐17F form either homo- or heterodimers and signal through IL-17 Receptor A (IL‐17RA) and IL‐17RC subunits (121) to promote inflammation.”
BackgroundInterleukin-17A genetic variants can confer resistance to brucellosis in Iranian population
Rasouli, M., Asaei, S., Kalani, M., Kiany, S., & Moravej, A. (2012) · Cytokine · doi:10.1016/j.cyto.2012.10.012 · Cited by 33
“Up to now, IL-17 family has six members including IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (IL-25) and IL17F, and there are five IL-17 receptors, IL-17RA, IL-17RB/IL-25R, IL-17RC, IL-17RD/SEF and IL-17RE [2].”
BackgroundInterleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage
Schminke, B., Trautmann, S., Mai, B., Miosge, N., & Blaschke, S. (2015) · European Journal of Immunology · doi:10.1002/eji.201545910 · Cited by 36
IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis
Huang, J., Yuan, Q., Zhu, H., Yin, L., Hong, S., Dong, Z., Jin, W., & Dong, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600977 · Cited by 30
Interleukin-17A Gene Expression in Morbidly Obese Women
Zapata-Gonzalez, F., Auguet, T., Aragonès, G., Guiu‐Jurado, E., Berlanga, A., Martínez, S., Martí, A., Sabench, F., Hernández, M., Aguilar, C., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817469 · Cited by 30
“In this regard, it has been reported that IL-17A can stimulate the production of IL-6 by activating such signaling pathways as NF-κB, Stat3 or PI3K/Akt [38].”
BackgroundYounesi, V., & Nejatollahi, F. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.10.015 · Cited by 28
Catar, R. A., Chen, L., Cuff, S. M., Kift-Morgan, A. P., Eberl, M., Kettritz, R., Kamhieh‐Milz, J., Moll, G., Li, Q., Zhao, H., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5438 · Cited by 36
“Many IL-17 target genes are thought to be activated through NF-κB, as their promoters are often enriched in NF-κB binding sites [18].”
BackgroundOnac, I. A., Clarke, B. D., Tacu, C., Lloyd, M. E., Hajela, V., Batty, T., Thoroughgood, J., Smith, S., Irvine, H., Hill, D., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab193 · Cited by 30
Zhao, L., Huang, J., Wu, S., Li, Y., & Pan, Y. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.09.039 · Cited by 29
Metadata
- Authors
- Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Gaffen, Sarah L.
- ORCID
- Gaffen, Sarah L.
- Venue
- Nature reviews. Immunology
- Published
- 2009-07-03
- Volume
- 9
- Issue
- 8
- Pages
- 556-567
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2821718
- OpenAlex
- W2020233428
- Cited by
- 1,475
- References
- 111
- Citations by year
- 2026: 66 · 2025: 87 · 2024: 57 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 76 · 2019: 96 · 2018: 81 · 2017: 92 · 2016: 108 · 2015: 91 · 2014: 107 · 2013: 89 · 2012: 90
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Update notices
- erratum (2009-08-07)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR054389)
- National Institute of Dental and Craniofacial Research (R21DE018822)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17RA, Th17 cells, cytokine signaling, signal transduction, innate and adaptive immunity, autoimmune disease, inflammatory pathology
- MeSH terms
- Animals, Autoimmune Diseases, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Signal Transduction, Cytokines, Interleukin-17, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.